<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>nephrology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>nephrology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="The National Registry of Rare Kidney Diseases (RaDaR): design, recruitment, and cross-sectional analyses of 25,880 adults and children with rare kidney diseases in the UK
Authors: Wong, K.; Pitcher, D.; Braddon, F.; Downward, L.; Steenkamp, R.; Annear, N.; Barratt, J.; Bingham, C.; Coward, R. J.; Chrysochou, T.; Game, D.; Griffin, S.; Hall, M.; Johnson, S.; Kanigicherla, D.; Karet Frankl, F.; Kavanagh, D.; Kerecuk, L.; Maher, E. R.; Moochhala, S.; Pinney, J.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/nephrology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="nephrology" />
<meta property="og:description" content="The National Registry of Rare Kidney Diseases (RaDaR): design, recruitment, and cross-sectional analyses of 25,880 adults and children with rare kidney diseases in the UK
Authors: Wong, K.; Pitcher, D.; Braddon, F.; Downward, L.; Steenkamp, R.; Annear, N.; Barratt, J.; Bingham, C.; Coward, R. J.; Chrysochou, T.; Game, D.; Griffin, S.; Hall, M.; Johnson, S.; Kanigicherla, D.; Karet Frankl, F.; Kavanagh, D.; Kerecuk, L.; Maher, E. R.; Moochhala, S.; Pinney, J." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/nephrology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-09-27T10:39:11+00:00" />
<meta property="article:modified_time" content="2023-09-27T10:39:11+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="nephrology"/>
<meta name="twitter:description" content="The National Registry of Rare Kidney Diseases (RaDaR): design, recruitment, and cross-sectional analyses of 25,880 adults and children with rare kidney diseases in the UK
Authors: Wong, K.; Pitcher, D.; Braddon, F.; Downward, L.; Steenkamp, R.; Annear, N.; Barratt, J.; Bingham, C.; Coward, R. J.; Chrysochou, T.; Game, D.; Griffin, S.; Hall, M.; Johnson, S.; Kanigicherla, D.; Karet Frankl, F.; Kavanagh, D.; Kerecuk, L.; Maher, E. R.; Moochhala, S.; Pinney, J."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "nephrology",
      "item": "https://trxiv.yorks0n.com/posts/nephrology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "nephrology",
  "name": "nephrology",
  "description": "The National Registry of Rare Kidney Diseases (RaDaR): design, recruitment, and cross-sectional analyses of 25,880 adults and children with rare kidney diseases in the UK\nAuthors: Wong, K.; Pitcher, D.; Braddon, F.; Downward, L.; Steenkamp, R.; Annear, N.; Barratt, J.; Bingham, C.; Coward, R. J.; Chrysochou, T.; Game, D.; Griffin, S.; Hall, M.; Johnson, S.; Kanigicherla, D.; Karet Frankl, F.; Kavanagh, D.; Kerecuk, L.; Maher, E. R.; Moochhala, S.; Pinney, J.",
  "keywords": [
    
  ],
  "articleBody": " The National Registry of Rare Kidney Diseases (RaDaR): design, recruitment, and cross-sectional analyses of 25,880 adults and children with rare kidney diseases in the UK\nAuthors: Wong, K.; Pitcher, D.; Braddon, F.; Downward, L.; Steenkamp, R.; Annear, N.; Barratt, J.; Bingham, C.; Coward, R. J.; Chrysochou, T.; Game, D.; Griffin, S.; Hall, M.; Johnson, S.; Kanigicherla, D.; Karet Frankl, F.; Kavanagh, D.; Kerecuk, L.; Maher, E. R.; Moochhala, S.; Pinney, J.; Sayer, J. A.; Simms, R.; Sinha, S.; Srivastava, S.; Tam, F. W. K.; Turner, A. N.; Walsh, S. B.; Waters, A.; Wilson, P.; Wong, E.; National Registry of Rare Kidney Diseases (RaDaR) Consortium, ; Sy, K. T. L.; Huang, K.; Ye, J.; Nitsch, D.; Saleem, M.; Bockenhauer, D.; Bramham, K.; Gale, D. P.\nScore: 14.4, Published: 2023-09-25 DOI: 10.1101/2023.09.24.23296009\nRare kidney diseases are not well characterised, despite making a significant contribution to the burden of kidney disease globally. The National Registry of Rare Kidney Diseases (RaDaR) collects longitudinal disease and treatment related data from people living with rare kidney diseases across the UK, and is the largest rare kidney disease registry in the world. We present the clinical demographics and renal function of 25,880 prevalent patients and evaluate for any potential recruitment bias to RaDaR. RaDaR recruits patients from 108 UK hospitals and is linked with the UK Renal Registry (UKRR, with which all UK patients receiving Kidney Replacement Therapy (KRT) are registered). To assess for recruitment bias to RaDaR we performed three comparisons of ethnicity and socioeconomic status: 1) All prevalent RaDaR patients receiving KRT were compared with patients with eligible rare disease diagnoses receiving KRT in the UKRR 2) Patients recruited to RaDaR and all eligible unrecruited patients at two renal centres were compared 3) The age-stratified ethnicity distribution RaDaR patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) was compared with the English Census. We observed over-representation of individuals reporting South Asian ethnicity in some rare diseases (most markedly Cystinosis and Primary Hyperoxaluria). We found no evidence of systematic bias in recruitment to RaDaR in terms of ethnicity or social deprivation. Predominant rare kidney diseases in adults ([\u0026ge;]18 years) were ADPKD (29.2%), Vasculitis (15.8%) and IgA nephropathy (15.7%), compared to Idiopathic nephrotic syndrome (43.6%), Vasculitis (10.8%) and Alport Syndrome (5.9%) in children (\u003c18 years). Compared with either adults recruited to RaDaR or the general UK population, children recruited to RaDaR were more likely to be of Asian ethnicity and live in more socially deprived areas.\nDeep learning on electronic medical records identifies distinct subphenotypes of diabetic kidney disease driven by genetic variations in the Rho pathway\nAuthors: Paranjpe, I.; Wang, X.; Anandakrishnan, N.; Haydak, J.; Van Vleck, T. T.; Defronzo, S.; Li, Z.; Mendoza, A.; Liu, R.; Fu, J.; Forrest, I.; Zhou, W.; Lee, K.; O'Hagan, R.; Dellepiane, S.; Menon, K.; Gulamali, F.; Kamat, S.; Gusella, G. L.; Charney, A. W.; Hofer, I.; Cho, J.; Do, R.; Glicksberg, B.; He, J.; Nadkarni, G.; Azeloglu, E. U.\nScore: 1.5, Published: 2023-09-07 DOI: 10.1101/2023.09.06.23295120\nAO_SCPLOWBSTRACTC_SCPLOWKidney disease affects 50% of all diabetic patients; however, prediction of disease progression has been challenging due to inherent disease heterogeneity. We use deep learning to identify novel genetic signatures prognostically associated with outcomes. Using autoencoders and unsupervised clustering of electronic health record data on 1,372 diabetic kidney disease patients, we establish two clusters with differential prevalence of end-stage kidney disease. Exome-wide associations identify a novel variant in ARHGEF18, a Rho guanine exchange factor specifically expressed in glomeruli. Overexpression of ARHGEF18 in human podocytes leads to impairments in focal adhesion architecture, cytoskeletal dynamics, cellular motility, and RhoA/Rac1 activation. Mutant GEF18 is resistant to ubiquitin mediated degradation leading to pathologically increased protein levels. Our findings uncover the first known disease-causing genetic variant that affects protein stability of a cytoskeletal regulator through impaired degradation, a potentially novel class of expression quantitative trait loci that can be therapeutically targeted.\n",
  "wordCount" : "641",
  "inLanguage": "en",
  "datePublished": "2023-09-27T10:39:11Z",
  "dateModified": "2023-09-27T10:39:11Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/nephrology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      nephrology
    </h1>
    <div class="post-meta"><span>updated on September 27, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.24.23296009">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.24.23296009" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.24.23296009">
        <p class="paperTitle">The National Registry of Rare Kidney Diseases (RaDaR): design, recruitment, and cross-sectional analyses of 25,880 adults and children with rare kidney diseases in the UK</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.24.23296009" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.24.23296009" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wong, K.; Pitcher, D.; Braddon, F.; Downward, L.; Steenkamp, R.; Annear, N.; Barratt, J.; Bingham, C.; Coward, R. J.; Chrysochou, T.; Game, D.; Griffin, S.; Hall, M.; Johnson, S.; Kanigicherla, D.; Karet Frankl, F.; Kavanagh, D.; Kerecuk, L.; Maher, E. R.; Moochhala, S.; Pinney, J.; Sayer, J. A.; Simms, R.; Sinha, S.; Srivastava, S.; Tam, F. W. K.; Turner, A. N.; Walsh, S. B.; Waters, A.; Wilson, P.; Wong, E.; National Registry of Rare Kidney Diseases (RaDaR) Consortium,  ; Sy, K. T. L.; Huang, K.; Ye, J.; Nitsch, D.; Saleem, M.; Bockenhauer, D.; Bramham, K.; Gale, D. P.</p>
        <p class="info">Score: 14.4, Published: 2023-09-25 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.24.23296009' target='https://doi.org/10.1101/2023.09.24.23296009'> 10.1101/2023.09.24.23296009</a></p>
        <p class="abstract">Rare kidney diseases are not well characterised, despite making a significant contribution to the burden of kidney disease globally. The National Registry of Rare Kidney Diseases (RaDaR) collects longitudinal disease and treatment related data from people living with rare kidney diseases across the UK, and is the largest rare kidney disease registry in the world. We present the clinical demographics and renal function of 25,880 prevalent patients and evaluate for any potential recruitment bias to RaDaR. RaDaR recruits patients from 108 UK hospitals and is linked with the UK Renal Registry (UKRR, with which all UK patients receiving Kidney Replacement Therapy (KRT) are registered). To assess for recruitment bias to RaDaR we performed three comparisons of ethnicity and socioeconomic status: 1) All prevalent RaDaR patients receiving KRT were compared with patients with eligible rare disease diagnoses receiving KRT in the UKRR 2) Patients recruited to RaDaR and all eligible unrecruited patients at two renal centres were compared 3) The age-stratified ethnicity distribution RaDaR patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) was compared with the English Census. We observed over-representation of individuals reporting South Asian ethnicity in some rare diseases (most markedly Cystinosis and Primary Hyperoxaluria). We found no evidence of systematic bias in recruitment to RaDaR in terms of ethnicity or social deprivation. Predominant rare kidney diseases in adults ([&amp;ge;]18 years) were ADPKD (29.2%), Vasculitis (15.8%) and IgA nephropathy (15.7%), compared to Idiopathic nephrotic syndrome (43.6%), Vasculitis (10.8%) and Alport Syndrome (5.9%) in children (&lt;18 years). Compared with either adults recruited to RaDaR or the general UK population, children recruited to RaDaR were more likely to be of Asian ethnicity and live in more socially deprived areas.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.09.06.23295120">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.09.06.23295120" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.09.06.23295120">
        <p class="paperTitle">Deep learning on electronic medical records identifies distinct subphenotypes of diabetic kidney disease driven by genetic variations in the Rho pathway</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.09.06.23295120" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.09.06.23295120" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Paranjpe, I.; Wang, X.; Anandakrishnan, N.; Haydak, J.; Van Vleck, T. T.; Defronzo, S.; Li, Z.; Mendoza, A.; Liu, R.; Fu, J.; Forrest, I.; Zhou, W.; Lee, K.; O&#39;Hagan, R.; Dellepiane, S.; Menon, K.; Gulamali, F.; Kamat, S.; Gusella, G. L.; Charney, A. W.; Hofer, I.; Cho, J.; Do, R.; Glicksberg, B.; He, J.; Nadkarni, G.; Azeloglu, E. U.</p>
        <p class="info">Score: 1.5, Published: 2023-09-07 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.09.06.23295120' target='https://doi.org/10.1101/2023.09.06.23295120'> 10.1101/2023.09.06.23295120</a></p>
        <p class="abstract">AO_SCPLOWBSTRACTC_SCPLOWKidney disease affects 50% of all diabetic patients; however, prediction of disease progression has been challenging due to inherent disease heterogeneity. We use deep learning to identify novel genetic signatures prognostically associated with outcomes. Using autoencoders and unsupervised clustering of electronic health record data on 1,372 diabetic kidney disease patients, we establish two clusters with differential prevalence of end-stage kidney disease. Exome-wide associations identify a novel variant in ARHGEF18, a Rho guanine exchange factor specifically expressed in glomeruli. Overexpression of ARHGEF18 in human podocytes leads to impairments in focal adhesion architecture, cytoskeletal dynamics, cellular motility, and RhoA/Rac1 activation. Mutant GEF18 is resistant to ubiquitin mediated degradation leading to pathologically increased protein levels. Our findings uncover the first known disease-causing genetic variant that affects protein stability of a cytoskeletal regulator through impaired degradation, a potentially novel class of expression quantitative trait loci that can be therapeutically targeted.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
